What is the starting dose of clonidine (antihypertensive/antiadrenergic medication) for patients, including adults with hypertension and pediatric patients with Attention Deficit Hyperactivity Disorder (ADHD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting Dose of Clonidine

For adults with hypertension, start clonidine at 0.1 mg twice daily (morning and bedtime), and for pediatric patients with ADHD, start at 0.05-0.1 mg orally at bedtime. 1, 2

Adult Hypertension Dosing

The FDA-approved starting dose for hypertension is 0.1 mg tablet twice daily (morning and bedtime), with elderly patients potentially benefiting from a lower initial dose. 1

Maintenance and Titration

  • Increase by 0.1 mg per day at weekly intervals if necessary until desired blood pressure response is achieved 1
  • Therapeutic doses most commonly range from 0.2 mg to 0.6 mg per day given in divided doses 1
  • Taking the larger portion of the daily dose at bedtime may minimize transient side effects of dry mouth and drowsiness 1
  • Maximum effective daily dose is 2.4 mg, though doses this high are rarely employed 1

Special Populations

  • Patients with renal impairment should start at a lower initial dose and be carefully monitored 1
  • Routine hemodialysis removes only minimal amounts of clonidine, so no supplemental dosing is needed following dialysis 1

Hypertensive Emergencies (Alternative Approach)

  • For rapid blood pressure control in hypertensive urgencies, an initial oral loading dose of 0.1-0.2 mg can be given, followed by hourly doses of 0.05-0.1 mg until goal blood pressure is attained or a total of 0.7-0.8 mg is administered 3, 4, 5
  • This approach achieves significant blood pressure reduction in approximately 82-93% of patients 3, 5

Pediatric ADHD Dosing

For children and adolescents aged 6-17 years with ADHD, begin with 0.05-0.1 mg orally at bedtime (QHS) to minimize initial sedation. 2, 6

Titration Schedule

  • Increase by 0.1 mg increments, divided into BID-TID dosing, based on clinical response and tolerability 2, 6
  • Maximum dose is 0.4 mg per day 2, 6
  • Therapeutic effects require 2-4 weeks before clinical benefits become apparent, unlike stimulants which work immediately 7

Clinical Positioning

  • Clonidine functions as an adjunct or second-line agent for ADHD, not first-line monotherapy 6
  • Extended-release clonidine and extended-release guanfacine are the only two medications with FDA approval for adjunctive use with stimulants in ADHD 7
  • Evening administration is generally preferable to minimize daytime somnolence 2

Monitoring Requirements

  • Assess blood pressure and heart rate at baseline and during dose adjustments 6
  • Monitor for common side effects including orthostatic hypotension, drowsiness, dry mouth, and sedation 8

Critical Safety Warning

Never abruptly discontinue clonidine—it must be tapered by 1 mg every 3-7 days to avoid rebound hypertension, which may precipitate hypertensive crisis. 8, 6

Common Pitfalls to Avoid

  • Do not expect immediate results in ADHD treatment—counsel families that 2-4 weeks are required for therapeutic effects 7
  • Do not use clonidine as first-line monotherapy for ADHD; stimulants remain first-line due to superior effect sizes 6
  • Avoid using clonidine for anxiety disorders, as this represents off-label use without established dosing protocols or strong efficacy evidence 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hypertensive emergencies treated with oral clonidine.

European journal of clinical pharmacology, 1986

Guideline

Clonidine Dosing and Usage Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guanfacine for ADHD Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Clonidine Dosage and Administration for Anxiety

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended dosage and usage of Clonidine (Clonidine) Extended Release (ER) for treating hypertension and Attention Deficit Hyperactivity Disorder (ADHD)?
What is the typical dosing for a clonidine (clonidine) patch for treating hypertension (high blood pressure) or attention deficit hyperactivity disorder (ADHD)?
What is the recommended dosage and usage of Clonidine (clonidine) for treating hypertension, Attention Deficit Hyperactivity Disorder (ADHD), and pain management?
What is the recommended dosing for clonidine (antihypertensive/alpha-2 adrenergic agonist) in treating hypertension and Attention Deficit Hyperactivity Disorder (ADHD)?
What is the next step in managing a patient with severely elevated blood pressure (hypertension) after administering clonidine (clonidine) 0.1?
What are the lung findings and management in a patient with suspected CREST (Calcinosis, Raynaud's phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia) syndrome without anti-CENP-B (Centromere Protein B) antibodies?
Is Clonidine (clonidine) 0.1 mg effective and safe for treating insomnia in adult patients, particularly those with a history of hypertension, kidney disease, or other comorbidities?
What is the best course of action for a 38-year-old male non-smoker without known comorbidities presenting with left upper lobe subsegmental atelectasis versus fibrosis on High-Resolution Computed Tomography (HRCT) scan?
What are the treatment options for a woman with Polycystic Ovary Syndrome (PCOS)?
What is the immediate treatment for a patient presenting with hyperkalemia?
What is the best treatment approach for a childbearing age woman with severe psoriasis covering her whole body?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.